You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Bulk Pharmaceutical API Sources for CHLOROPROCAINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for CHLOROPROCAINE HYDROCHLORIDE

Vendor Vendor Homepage Vendor Sku API Url
Molport ⤷  Get Started Free MolPort-006-115-755 ⤷  Get Started Free
AvaChem Scientific ⤷  Get Started Free 3858-89-7 ⤷  Get Started Free
AvaChem Scientific ⤷  Get Started Free 2816 ⤷  Get Started Free
TargetMol ⤷  Get Started Free T6443 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS027382305 ⤷  Get Started Free
ChemShuttle ⤷  Get Started Free 141781 ⤷  Get Started Free
LGC Standards ⤷  Get Started Free LGCFOR1994.00 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: CHLOROPROCAINE HYDROCHLORIDE

Last updated: July 30, 2025


Introduction

Chloroprocaine hydrochloride is a short-acting local anesthetic widely used in regional anesthesia, infiltration anesthesia, and epidural procedures. Its clinical efficacy hinges not only on formulation but also on reliable, high-quality bulk API sourcing. This article provides a comprehensive overview of globally recognized suppliers and considerations for sourcing Chloroprocaine hydrochloride API, emphasizing quality, regulatory compliance, and supply chain robustness.


Understanding Chloroprocaine Hydrochloride API

Chloroprocaine hydrochloride is a synthetic ester-type local anesthetic with rapid onset and brief duration. Its chemical stability, purity, and consistent supply are imperative for pharmaceutical manufacturers aiming to produce effective and safe formulations. As with other APIs, sourcing involves evaluating manufacturer reputation, regulatory adherence, manufacturing quality control, and supply chain reliability.


Global API Suppliers for Chloroprocaine Hydrochloride

1. Established Indian Manufacturers

India remains a dominant player in generic API manufacturing, offering cost-effective, high-quality APIs for the global market. Several Indian companies have demonstrated expertise in ester local anesthetics, including Chloroprocaine hydrochloride:

  • Sun Pharma Laboratories Ltd.
    A leading Indian pharmaceutical company with extensive API manufacturing capabilities, including ester-type anesthetics. Their facilities adhere to strict cGMP standards, and they possess multiple regulatory approvals (FDA, PCA, MHRA)[1].

  • Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. (China)
    A significant Asian API supplier with a focus on anesthetics. Their manufacturing facilities follow international quality standards, offering reliable Chloroprocaine hydrochloride API[2].

  • Lupin Limited
    Known for a wide portfolio of APIs with ISO-certified plants. Lupin’s manufacturing processes emphasize purity, consistency, and regulatory compliance[3].

2. European API Manufacturers

European API producers often cater to stringent regulatory markets, emphasizing quality and compliance:

  • BASF SE (Germany)
    A globally recognized chemical and pharmaceutical ingredient manufacturer. BASF’s API division supplies specialty pharmaceuticals, including local anesthetics, with assured quality standards. Their facilities are compliant with EMA and FDA regulations[4].

  • Fresenius Kabi AG (Germany)
    Specializes in injectable APIs, including local anesthetic intermediates. Their manufacturing processes follow strict cGMP and ISO standards, with focus on purity and safety[5].

3. Chinese API Manufacturers

China has rapidly expanded its pharmaceutical API industry, with many manufacturers capable of producing Chloroprocaine hydrochloride at scale:

  • Hubei Widely Chemical Co., Ltd.
    They produce ester-type anesthetic APIs for export, emphasizing competitive pricing and quality. They hold several certifications aligned with international standards[6].

  • Shandong Xinhua Pharmaceutical Co., Ltd.
    Offers a range of APIs including local anesthetics, with a focus on cost-effective manufacturing and modern quality control measures[7].

4. North American API Suppliers

While fewer in number, North America hosts high-quality API manufacturers, primarily serving domestic markets and collaborations:

  • FDA-registered API manufacturers in the U.S.
    Such facilities adhere strictly to cGMP, with some offering Chloroprocaine hydrochloride API for specialized needs. Companies like Northeast Pharmaceutical or ABI-Pharma may provide sourcing options, subject to regulatory approval[8].

Key Factors for Selecting API Suppliers

  1. Regulatory Compliance and Certifications:
    Verify if suppliers hold certifications such as cGMP, ISO, PIC/S, or other relevant regulatory standards. For export and regulatory approval, compliant documentation and dossier support are essential.

  2. Purity and Quality Assurance:
    The API must meet pharmacopoeial standards (USP, EP, JP) for potency, residual solvents, endotoxins, and impurities. Analytical testing reports and batch certificates are critical.

  3. Manufacturing Capacity and Reliability:
    Consistent supply depends on robust manufacturing capacity, contingency plans, and supply chain transparency.

  4. Pricing and Payment Terms:
    Competitive pricing without compromising quality is necessary. Consider long-term contractual arrangements to stabilize supply.

  5. Logistics and Lead Times:
    Evaluate shipping capabilities, customs clearance efficiency, and lead times to ensure timely production schedules.


Regulatory and Compliance Considerations

Compliance with international regulatory bodies safeguards against market access issues. Suppliers should provide comprehensive dossiers, Certificates of Analysis (CoA), Certificates of Origin, and stability data. Manufacturers with WHO-GMP, FDA-validated facilities, or EMA approval are preferred, ensuring quality and facilitating regulatory approval of finished pharmaceutical products.


Emerging Trends and Challenges

  • Regulatory Stringency: Increased scrutiny and tighter registration requirements necessitate thorough due diligence.

  • Supply Chain Disruptions: Geopolitical tensions, pandemics, and shipping bottlenecks challenge supply reliability; diversification across multiple suppliers mitigates risks.

  • Quality Upgrades: The shift toward high-purity APIs aligns with regulatory expectations and reduces adverse effects linked with impurities.


Conclusion

Sourcing high-quality Chloroprocaine hydrochloride API requires meticulous evaluation of suppliers' regulatory status, manufacturing standards, and supply capacity. Indian, European, and Chinese manufacturers currently dominate the market, providing viable options across various price points and quality standards. Ensuring compliance and establishing long-term partnerships are crucial for pharmaceutical companies seeking reliable API sources for Chloroprocaine hydrochloride.


Key Takeaways

  • The API market for Chloroprocaine hydrochloride is globally diverse, with notable suppliers in India, China, Europe, and North America.
  • Prioritize suppliers with proven regulatory compliance (cGMP, ISO certifications) and transparent quality assurance documentation.
  • Reliable supply chains depend on evaluating manufacturing capacity, logistics capabilities, and contingency planning.
  • Diversification across multiple suppliers minimizes supply risks amid geopolitical or logistical disruptions.
  • Engaging with suppliers early in the development process facilitates regulatory approval and quality assurance.

FAQs

Q1: What are the main factors affecting the quality of Chloroprocaine hydrochloride API?
A1: Purity, residual solvent levels, impurity profile, potency, and batch consistency, all verified through rigorous analytical testing and regulatory compliance.

Q2: How can I verify the regulatory compliance of an API supplier?
A2: Request certifications such as cGMP, ISO, PIC/S, and review batch documentation, quality certificates, and regulatory approvals from relevant health authorities.

Q3: Are there risks associated with sourcing APIs from China or India?
A3: Risks include variability in quality, regulatory differences, and supply chain disruptions. Mitigation involves thorough supplier assessment, audits, and diversification.

Q4: What role do regulatory agencies like the FDA or EMA play in API sourcing?
A4: They establish quality standards, approve manufacturing facilities, and oversee compliance, ensuring APIs meet safety, efficacy, and quality parameters.

Q5: How does the choice of API supplier impact pharmaceutical manufacturing?
A5: It influences product safety, efficacy, regulatory approval process, manufacturing cost, and supply chain stability. Selecting reputable suppliers enhances product reliability and market access.


References
[1] Sun Pharma Annual Report, 2022.
[2] Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. Quality Certification.
[3] Lupin Limited API dossier, 2022.
[4] BASF SE API Portfolio, 2023.
[5] Fresenius Kabi: API Manufacturing Standards, 2022.
[6] Hubei Widely Chemical Co., Ltd. Certifications, 2022.
[7] Shandong Xinhua Pharmaceutical Co., Ltd. Product Data Sheet, 2023.
[8] FDA Database of Active Pharmaceutical Ingredient Manufacturers, 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.